Modulation of platelet-activating-factor production by incorporation of naturally occurring 1-O-alkylglycerols in phospholipids of human leukemic monocyte-like THP-1 cells

European Journal of Biochemistry

Volumn 250, Issue 2, 1997, Pages 242-248

  Hichami, Aziz ^a   Duroudier, Valéric ^a   Leblais, Véronique ^a   Vernhet, Laurent ^a   Le Goffic, François ^b   Ninio, Ewa ^c   Legrand, Alain ^a,d  

^a UNIVERSITÉ DE RENNES 1   (France)

^b CNRS   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d Lab de Pharmacologie Molec   (France)

Author keywords

Alkylglycerol; Phospholipid; Platelet aggregation; Platelet activating factor

Indexed keywords

CALCIMYCIN; FOROPAFANT; GLYCEROL DERIVATIVE; PHOSPHOLIPID; THROMBOCYTE ACTIVATING FACTOR;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKEMIA CELL; LIPOGENESIS; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION;

EID: 0031467248     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-1033.1997.0242a.x     Document Type: Article

References (32)

1. Brohult, A., Brohult, J. & Brohult, S. (1970) Biochemical effects of alkoxyglycerols & their use in cancer therapy, Acta Chem. Scand. 24, 730-732.
2. Brohult, A. (1963) Alkoxyglycerols and their use in radiation treatment, Acta Radiol. Suppl. 223, 1-99.
3. Brohult, A., Brohult, J., Brohult, S. & Joelsson, I. (1986) Reduced mortality in cancer patients after administration of alkoxyglycerols, Acta Obstet. Gynecol. Scand. 65, 779-785.
4. Brohult, A., Brohult, J. & Brohult, S. (1978) Regression of tumour growth after administration of alkoxyglycerols, Acta Obstet. Gynecol. Scand. 57, 79-83.
5. Diomede, L., Colotta, F., Piovani, B., Re, F., Modest, E. J. & Salmona, M. (1993) Induction of apoptosis in human leukemic cells by ether lipid 1-octadecyl-2-methyl-rac-glycero-3-phosphocholine. A possible basis for its selective action. Int. J. Cancer 53, 124-130.
6. Blank, M. L., Cress, E. A., Smith, Z. L. & Snyder, F. (1991) Dietary supplementation with ether-linked lipids and tissue lipid composition. Lipids 26, 166-169.
7. Reichwald, I. & Mangold, H. K. (1977) Assessment of the specificity of enzymatic reactions using mixed substrates: Incorporation of alkylglycerols in the ionic alkoxylipids of rat intestinal mucosa. Nutr. Metab. 21 (Suppl. 1), 198-201.
8. Koltai, M., Hosford, D., Guinot, P., Esanu, A. & Braquet, P. (1991) Platelet-activating factor (PAF). A review of its effects, antagonists and possible future clinical implications (Part I), Drugs 42, 9-29.
9. Koltai, M., Hosford, D., Guinot, P., Esanu, A. & Braquet, P. (1991) Platelet-activating factor (PAF). A review of its effects, antagonists and possible future clinical implications (Part II), Drugs 42, 174-204.
10. Triggiani, M., Schleimer, R. P., Warner, J. A. & Chilton, F. D. (1991) Differential synthesis of 1-acyl-2-acelyl-sn-glycero-3-phosphocholine and platelet-activating factor by human inflammatory cells. J. Immunol. 147, 660-666.
11. Tsuchiya, S., Yamabe, M., Yamaguchi, Y., Kobayashi, Y., Konno, T. & Tada, K. (1980) Establishment and characterization of a human acute monocytic leukemia cell line (THP-1), Int. J. Cancer 26, 171-176.
12. Dentan, C., Lesnik, P., Chapman, J. & Ninio, E. (1996) Phagocytic activation induces formation of platelet-activating factor in human monocyte-derived macrophages and in macrophage-derived foam cells. Relevance to the inflammatory reaction in atherogenesis. Eur. J. Biochem. 236, 48-55.
13. Bligh, E. G. & Dyer, W. J. (1959) A rapid method of total lipid extraction and purification, Can. J. Biochem. Physiol. 37, 911-917.
14. Bossant, M. J., Ninio, E., Delautier, D. & Benveniste, J. (1990) Bioassay of platelet-activating acether factor by rabbit platelet aggregation. Methods Enzymol. 187, 125-130.
15. Benveniste, J., Le Couedic, J. P., Polonsky, J. & Tence M. (1977) Structural analysis of purified platelet-activating factor by lipases, Nature 269, 170-171.
16. Ninio, E., Maiza, H., & Bidault, J. (1993) Autocrine amplification of PAF-acether formation in immunologically activated murine macrophages, J. Leukocyte Biol. 54, 296-299.
17. Snyder, F. (1991) Metabolism, regulation, and function of ether-linked glycerolipids and their bioactive species, in Biochemistry of lipids, lipoproteins and membranes (Vance, D. E. & Vance, J. E., eds) pp. 241-267, Elsevier Science B. V., Amsterdam.
18. Blank, M. L., Fitzgerald, V., Lee, T. & Snyder, F. (1993) Evidence for biosynthesis of plasmenylcholine from plasmenylethanolamine in HL-60 cells, Biochem. Biophys. Acta 1166, 309-312.
19. Braquet, P., Touqui, L., Shen, T. Y. & Vargaftig, B. B. (1987) Perspectives in platelet-activating factor research. Pharmacol. Rev. 39, 97-145.
20. Marcheselli, V. L., Rossowska, M. J., Domingo, M. T., Braquet, P. & Bazan, N. G. (1990) Distinct platelet-activating factor binding sites in synaptic endings and in intracellular membranes of rat cerebral cortex, J. Biol. Chem. 265, 9140-9145.
21. Marcheselli, V. L., & Bazan, N. G., (1994) Platelet-activating factor is a messager in the electroconvulsive shock-induced transcriptional activation of c-fos and zif-268 in hippocampus, J. Neurosci. Res. 37, 54-61.
22. Squinto, S. P., Block, A. L., Braquet, P. & Bazan, N. G. (1989) Platelet-activating factor stimulates a fos/jun/AP-1 transcriptional signaling system in human neuroblastoma cells, J. Neurosci. Res. 24, 558-566.
23. Jouvin-Marche, E., Ninio, E., Beaurain, G., Tence, M., Niaudet, P. & Benveniste, J. (1984) Biosynthesis of PAF-acether (platelet-activating factor) VII. Precursors of PAF-acether and acetyl-transferase activity in human leucocytes, J. Immunol. 133, 892-898.
24. Snyder, F. (1995) Platelet-activating factor: the biosynthetic and catabolic enzymes, Biochem. J. 305, 689-705.
25. Snyder, F. (1989) Biochemistry of platelet-activating factor: a unique class of biologically active phospholipids, Proc. Soc. Exp. Biol. Med. 190, 125-135.
26. Ramesha, C. S. & Pickett, W. C. (1987) Species-specific variations in the molecular heterogeneity of the platelet-activating factor, J. Immunol 138, 1559-1563.
27. Mueller, H. W., O'Flaherty, J. T. & Wykle, R. L. (1984) The molecular species distribution of platelet-activating factor synthetized by rabit and human neutrophils, J. Biol. Chem. 259, 14554-14559.
28. McManus, L. M., Woodard, D. S., Deavers, S. I. & Pinckard, R. N. (1993) PAF molecular heterogeneity: pathobiological implications, Lab. Invest. 69, 639-650.
29. Oh, S. Y. & Jadhav, L. S. (1994) Effects of dietary alkylglycerols in lactating rats on immune responses in pups. Pediatr. Res. 36, 300-305.
30. Sturk, A., Schaap, M. C. L., Prins, A., Ten Cat, J. W., Govaerts, L. C. P., Wanders, R. J. A., Heymans, H. S. A. & Schutgens, R. B. H. (1987) Age related deficiency of the synthesis of platelet activating factor by leukocytes from Zellweger patients. Blood 70, 460-463.
31. Schrakamp, G., Roosenboom, C. F. P., Schutgens, R. B. H., Wanders, R. J. A., Heymans H. S. A. & Van Den Bosch, H. (1985) Alkyl dihydroxyacetone phosphate synthase in human fibroblasts and its deficiency in Zellweger syndrome, J. Lipid Res. 26, 867-873.
32. Van Den Bosch, H., Schrakamp, G., Hardeman, D., Zomer, A. W. M., Wanders, R. J. A. & Schutgens R. B. H. (1993) Ether lipid synthesis and its deficiency in peroxisomal disorders, Biochemie (Paris) 75, 183-189.